Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: Sep 14, 2026, 4:00 PM EDT
1.400
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:10 PM EDT

OKYO Pharma Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal QuarterH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period EndingMar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Gross Profit
-4.14-2.55-3.71-1.12-3.37-4.13-3.86-2.69-2.47-2.19
Operating Income
-6-2.5-3.75-3.34-7.02-8.73-7.55-5.08-3.63-2.66
Net Income
-6.36-2.59-2.03-2.68-8.01-8.82-7.64-5.08-3.02-2.48
Earnings Per Share
-0.17-0.07-0.04-0.08-0.24-0.34-0.33-0.23-0.19-0.18
EPS Growth
----------

Cash & Debt
Chart
Fiscal QuarterH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period EndingMar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Cash & Investments
20.594.221.560.990.83-4.050.712.75.2
Total Debt
-0.19-0--2.22--0.08
Net Cash (Debt)
20.594.031.560.990.83-1.830.712.75.12
Net Cash Growth
1219.38%309.44%88.78%--54.82%--32.23%-86.20%-60.16%-31.07%
Net Cash Per Share
0.550.110.030.030.03-0.080.030.170.37

Cash Flow & CapEx
Chart
Fiscal QuarterH2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period EndingMar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Operating Cash Flow
-4.41-1.53-1.57-0.24-2.7-6.79-4.1-3.24-2.61-2.94
Capital Expenditures
-0.01--0----0-0-0-
Free Cash Flow
-4.41-1.53-1.57-0.24-2.7-6.79-4.11-3.24-2.61-2.94
Free Cash Flow Growth
----------

Valuation
Selected indicators aren't available for this stock.